Cetuximab, fluorouracil and cisplatin with or without docetaxel for patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck (CeFCiD): an open-label phase II randomised trial (AIO/IAG-KHT trial 1108)
Klinghammer, K., Gauler, T., Dietz, A., Grünwald, V., Stöhlmacher, J., Knipping, S., Schroeder, M., Guntinas-Lichius, O., Frickhofen, N., Lindeman, H.-W., Fietkau, R., Haxel, B., Große-Thie, C., Maschmeyer, G., Zipfel, M., Martus, P., Knoedler, M., Keilholz, U.
Published in European journal of cancer (1990) (01.11.2019)
Published in European journal of cancer (1990) (01.11.2019)
Get full text
Journal Article
sCD14 in Bronchoalveolar Lavage 18, 42 and 162 Hours After Segmental Allergen Provocation
Julius, P, Grosse-Thie, C, Kuepper, M, Bratke, K, Virchow, J.C
Published in Scandinavian journal of immunology (01.04.2010)
Published in Scandinavian journal of immunology (01.04.2010)
Get full text
Journal Article
A two-arm multicenter phase II trial of one cycle chemoselection split-dose docetaxel, cisplatin and 5-fluorouracil (TPF) induction chemotherapy before two cycles of split TPF followed by curative surgery combined with postoperative radiotherapy in patients with locally advanced oral and oropharyngeal squamous cell cancer (TISOC-1)
Inhestern, J., Schmalenberg, H., Dietz, A., Rotter, N., Maschmeyer, G., Jungehülsing, M., Grosse-Thie, C., Kuhnt, T., Görner, M., Sudhoff, H., Wittekindt, C., Guntinas-Lichius, O.
Published in Annals of oncology (01.08.2017)
Published in Annals of oncology (01.08.2017)
Get full text
Journal Article
Übersetzung eines geeigneten Instruments zur Messung der Lebensqualität und Symptomkontrolle von stationär und ambulant betreuten Palliativpatienten (FACIT-Pal) sowie eines Fragebogens zur Betreuungszufriedenheit ihrer Angehörigen (FAMCARE-2)
Sewtz, C, Hlawa, W, Kragl, B, Panse, J, Kriesen, U, Große-Thie, C, Junghanß, C
Published in Zeitschrift für Palliativmedizin (16.05.2014)
Published in Zeitschrift für Palliativmedizin (16.05.2014)
Get full text
Conference Proceeding
Lösliches CD14 (sCD14) 18, 42 und 162 Stunden nach segmentaler Allergenprovokation allergischer Asthmatiker
Julius, P, Große-Thie, C, Küpper, M, Bratke, K, Luttmann, W, Fähndrich, S, Virschow, JC
Published in Pneumologie (03.03.2005)
Published in Pneumologie (03.03.2005)
Get full text
Conference Proceeding